Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Sucampo's cobiprostone granted fast track designation for oral mucositis

May 8, 2015

Oral Health Australia reports propeptides for periodontal diseases

Dec. 12, 2014

Liquidia forms oral health company Lq3 Pharmaceuticals

Sep. 16, 2014

C3 Jian completes phase II trial of C16G2

Sep. 10, 2014

C3 Jian begins phase II study of C-16G2 for prevention of dental caries

March 10, 2014

Soligenix begins phase II trial of SGX-942 for the treatment of oral mucositis

Dec. 12, 2013

Interleukin Genetics to launch PerioPredict periodontal disease test

Nov. 28, 2013

Clinical characterization of a novel pleiotropic anti-inflammatory effect of high-dose statin

Oct. 22, 2013

Acacia Pharma's phase II trial of APD-515 for xerostomia meets primary endpoint

Oct. 15, 2013

C3 Jian completes phase I trial of therapeutic for prevention of tooth decay

Aug. 23, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...